The research progress in HAART-related hyperlactacidemia/lactic acidosis in HIV/AIDS patients
Hongxi Zhao
Abstract
Hongxi Zhao
Abstract
Since HAART are taken in AIDS patients in developing countries,the morbidity and mortality of opportunistic infections have been significantly reduced.Since 2003,free HAART treatment have been carried out with support of the Chinese government,in which nucleoside analogs such as stavudine,zidovudine or didanosine are treated as backbone.The main side effect of nucleoside analogs is mitochondrial toxicity,resulting in hyperlactacidemia/lactic acidosis.In this review,we have summarized the incidence,mechanisms,clinical manifestations,diagnosis,treatment and prognosis of hyperlactacidemia/lactic acidosis in HIV/AIDS patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Since HAART are taken in AIDS patients in developing countries,the morbidity and mortality of opportunistic infections have been significantly reduced.Since 2003,free HAART treatment have been carried out with support of the Chinese government,in which nucleoside analogs such as stavudine,zidovudine or didanosine are treated as backbone.The main side effect of nucleoside analogs is mitochondrial toxicity,resulting in hyperlactacidemia/lactic acidosis.In this review,we have summarized the incidence,mechanisms,clinical manifestations,diagnosis,treatment and prognosis of hyperlactacidemia/lactic acidosis in HIV/AIDS patients.
Key concepts: Didanosine, Lactic acidosis, Stavudine, Medicine, Acidosis, Zidovudine, Human immunodeficiency virus (HIV), Nucleoside analogue